Uptake and kinetics of 14C-labelled meta-tetrahydroxyphenylchlorin and 5-aminolaevulinic acid in the C6 rat glioma model
1998

Study of m-THPC and 5-ALA in Brain Tumors

Sample size: 4 publication Evidence: moderate

Author Information

Author(s): A Obwegeser, R Jakober, H Kostron

Primary Institution: Department of Neurosurgery, University of Innsbruck

Hypothesis

The study aims to investigate and compare the uptake of 5-ALA and m-THPC in brain tumor and normal tissue using a rat glioma model.

Conclusion

The study provides basic information for choosing the optimal timing for photodynamic therapy and diagnosis with m-THPC or 5-ALA in brain tumors.

Supporting Evidence

  • The study found a significantly higher uptake of m-THPC and 5-ALA in glioma tissue than in normal brain.
  • m-THPC showed a brain-tumor ratio of over 1:80 between 36 and 48 hours.
  • 5-ALA showed rapid uptake in tumor tissue, with significant differences observed at various time points.

Takeaway

This study looked at how two special medicines, m-THPC and 5-ALA, work in brain tumors in rats. It found that m-THPC is better for treating tumors, while 5-ALA is good for helping doctors see the tumors.

Methodology

The study used a rat glioma model to measure the uptake of radiolabelled m-THPC and 5-ALA in tumor and normal tissues.

Limitations

The study was conducted in a rat model, which may not fully represent human responses.

Participant Demographics

Female Sprague-Dawley rats weighing approximately 160 g were used.

Statistical Information

P-Value

p<0.0001

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication